Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 randomized double-blind trial of Qingfei Xiaoyan Wan with goat horn versus original antelope horn formulation for acute exacerbation of chronic bronchitis
CTR20213437Phase 3Active
- Sponsor
- Darentang
- Start
- Mar 2022
- Countries
- 1
01
Overview
A Phase 3 trial of Qingfei Xiaoyan Wan in chronic bronchitis (CB), sponsored by Darentang. Started Mar 2022; status: active.
02
Drugs
Qingfei Xiaoyan Wan
03
Conditions
chronic bronchitis (CB)
Beyond the preview
Go deeper on CTR20213437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20213437.